Martin Stockler

17.1K posts

Martin Stockler banner
Martin Stockler

Martin Stockler

@MartinStockler

Grappling with oncology, clinical research, quality of life, prognostication, communication, education, rabbitohs, wallabies, cricket, and other enigmas

Earth Katılım Ağustos 2010
3.7K Takip Edilen2.6K Takipçiler
Martin Stockler retweetledi
Martin Stockler retweetledi
Jia (Jenny) Liu MD PhD
Jia (Jenny) Liu MD PhD@JiaJennyLiu·
2011 PhD student → 2025 drug development oncologist. A long road, a lot of growth, and so many people to thank along the way. Grateful to be promoted to Conjoint Associate Professor at @UNSW. Excited for the next stage of global collaboration in early phase trials 🧬🧫🔬👩🏻‍⚕️
Jia (Jenny) Liu MD PhD tweet media
English
0
1
18
715
Martin Stockler retweetledi
Advanced Prostate Cancer Consensus Conference
Optimal Duration of Androgen Deprivation Therapy With Definitive Radiotherapy for Localized Prostate Cancer: Meta-Analysis jamanetwork.com/journals/jamao… Meta-analysis of over 10,000 patients from 13 randomized trials found that the survival benefit of androgen deprivation therapy (ADT) combined with radiotherapy is highly dependent on both treatment duration and patient risk profile, with diminishing returns beyond roughly 9–12 months and increasing non–cancer-related mortality with prolonged therapy. Optimal duration varied by disease severity—shorter or no ADT for lower-risk intermediate disease, longer courses for higher-risk groups—highlighting that extended therapy is not universally beneficial. Because longer ADT improves cancer-specific outcomes but also increases other-cause mortality, the study emphasizes tailoring duration based on individual risk, comorbidities, life expectancy, and patient preference rather than applying uniform treatment lengths. #ProstateCancer @NicholasZaorsky @yilun_sun @StatMatt9 @DrHowardSandler @drjefstathiou @Soum_Roy_RadOnc @DrPaulNguyen @jeshoag @PBarataMD @angela_jia_ @MSteinbergMD @AmarUKishan @DrSpratticus @OncoAlert 🚨 @Silke_Gillessen @AOmlin @weoncologists
Advanced Prostate Cancer Consensus Conference tweet media
English
1
40
106
9.8K
Martin Stockler retweetledi
Jia (Jenny) Liu MD PhD
Jia (Jenny) Liu MD PhD@JiaJennyLiu·
Just published a paper co-authored with early-phase trial patients. It took far longer than it should have… a sign of how undervalued patient experience still is in oncology. Cancer drug development must be human-centred, not just molecule-centred. 🔗: oncotarget.com/article/28776/…
Jia (Jenny) Liu MD PhD tweet media
English
1
6
15
1.6K
Martin Stockler retweetledi
Advanced Prostate Cancer Consensus Conference
ENZARAD (ANZUP 1303) Presented at #ESMO25 ADT with radiation therapy with or without enzalutamide for high risk, clinically localised #ProstateCancer cslide.ctimeetingtech.com/esmo2025/atten… Adding enzalutamide to ADT 💊and radiation provided limited overall survival benefit in high-risk localized or locally advanced prostate cancer, with greater metastasis-free survival seen in patients with positive pelvic nodes or planned pelvic radiation☢️ @DrPaulNguyen @ChrisSweens1 @MartinStockler @DocJarad @DavePryorRO @PaulKRadiation @Prof_IanD @OncoAlert 🚨 @Silke_Gillessen @AOmlin @nataliagandur @bavilima
Advanced Prostate Cancer Consensus Conference tweet media
English
0
13
30
2.9K
Martin Stockler retweetledi
Linda Mileshkin
Linda Mileshkin@LindaMileshkin·
Great way to start Day 2 of #IGCS2025 with a Run for Hope to raise funds for Gynae cancer!
Linda Mileshkin tweet mediaLinda Mileshkin tweet mediaLinda Mileshkin tweet mediaLinda Mileshkin tweet media
English
0
3
6
311
Martin Stockler retweetledi
Linda Mileshkin
Linda Mileshkin@LindaMileshkin·
The discussant @ShannonWestin intrigued by the OS curves in the ECHO trial which although not significant currently may improve with time. Also pointing out that PFS was excellent in both arms.
Linda Mileshkin tweet mediaLinda Mileshkin tweet media
Linda Mileshkin@LindaMileshkin

Well done on a great presentation of the @anzgog ECHO trial by Sandy Hayes at #IGCS2025 this am. Why were the results different from the Challenge trial? Reassuring for women having chemo for ovarian cancer to know that if they don’t feeling like walking every day it is ok!

English
0
2
4
356
Martin Stockler retweetledi
Linda Mileshkin
Linda Mileshkin@LindaMileshkin·
Well done on a great presentation of the @anzgog ECHO trial by Sandy Hayes at #IGCS2025 this am. Why were the results different from the Challenge trial? Reassuring for women having chemo for ovarian cancer to know that if they don’t feeling like walking every day it is ok!
Linda Mileshkin tweet mediaLinda Mileshkin tweet mediaLinda Mileshkin tweet mediaLinda Mileshkin tweet media
Angeles Secord@AngelesSecord

#IGCS2025 Congratulations Dr. Hayes!! Even though exercise did not improve PFS or OS or physical well being it was an amazing study and effort!! 🥰❤️🥰 still hopeful that exercise programs can improve outcomes for some. Still work to do!!

English
1
2
8
1K
Martin Stockler retweetledi
Prof Lennart Nacke, PhD
Prof Lennart Nacke, PhD@acagamic·
Rejected within 24 hours. That’s how my academic journey really started. My writing has never been the same since. Here’s what I learned from 300+ submissions: Too many papers get rejected instantly.
Prof Lennart Nacke, PhD tweet media
English
12
311
1.6K
145.1K
Martin Stockler retweetledi
Aparna Raj Parikh
Aparna Raj Parikh@aparna1024·
Honored to be named Program Director for GI Medical Oncology @MGHCancerCenter , focused on CRC, Anal & NET. Grateful to collaborate with incredible colleagues like @KlempnerSam leading UGI and Harsh Singh joining us for HBP. excited to build on innovation & equity in cancer care.
English
21
7
142
7.6K
Martin Stockler retweetledi
bhawna sirohi
bhawna sirohi@SirohiBhawna·
What an amazing feat the @BalcoMedical team pulled off .. meeting attended by >1000 with almost 200 from india, 12 globally from australia, NZ, UK, USA, Lebanon, Switzerland, singapore. key tracks were mini Accord research workshop, communication skills with role play to train Oncologist into communicating prognosis and having end of life conversations with the patients and caregivers, radiotherapy contouring workshop, surgery workshop for head neck cancers. choosing wisely themed GIGU and lung Cancer, cancer prevention workshop, which mainly discussed HPV vaccine implementation, district level cancer prevention programmes. This was attended by state level, health officers and on ground level. Mitanin/Asha workers from Chhattisgarh. meeting was attended by 65 oncology students all over the country. Top 10 posters will be published in @ecancer . Looking forward to September 2026, .. have an amazing line up of @oncology_bg , ian prof Tannock, @prof_gina_brown @ajumathew_ @lateuwen and more ! Thank you to @TataMemorial @ACTREC_TMC @CancerGridIndia @ASCO @myESMO @csoncol @Shrikhande_SV @JavleMilind @MDAndersonNews @VanitaNoronha @nitaSnair
bhawna sirohi tweet mediabhawna sirohi tweet mediabhawna sirohi tweet mediabhawna sirohi tweet media
English
4
14
45
4.6K
Martin Stockler retweetledi
bhawna sirohi
bhawna sirohi@SirohiBhawna·
So grateful to our health minister honourable @ShyamBihariBjp for inaugurating the @BalcoMedical annual conclave and inspiring us to serve the nation ! Spoke so eloquently on the importance of health for all especially women as part of स्वस्थ नारी सशक्त परिवार स्वास्थ्य प्रदेश स्वास्थ्य भारत विकसित भारत अभियान!! Thank you 🙏🏽 @MartinStockler @drkiwicj @drshonanag @pankajpanda86 @aparna1024 @SusannahStanwa1 @y2k2011
bhawna sirohi tweet mediabhawna sirohi tweet mediabhawna sirohi tweet mediabhawna sirohi tweet media
0
5
11
497